Search clinical trials for: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2

Total 771 results

Sanofi Pasteur, a Sanofi Company

Completed

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (VAD00001)

Respiratory Syncytial Virus Infection

Honduras, United States, Chile
Stanford University

Completed

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Covid19

Australia
Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

SARS-CoV-2

United States
Central Hospital, Nancy, France
University of Lorraine; Métropole du Grand Nancy

Completed

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) (COVAL-NANCY)

Coronavirus Infection | Prevalence

France
Baiya Phytopharm Co., Ltd.

Not yet recruiting

Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

COVID-19 | COVID-19 Vaccine

Thailand
Institute for Clinical and Experimental Medicine

Completed

IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA) (TASMANIA)

Kidney Transplantation

Czechia
University Hospital, Montpellier

Terminated

REassessement After Hospitalization for Sars-COV-2 disordER (REHCOVER)

Sars-CoV2

France
Grand Hôpital de Charleroi

Completed

COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Covid19

Belgium
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Papillomavirus Infections | Coronavirus Disease (COVID-19)

United States
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Transplacental Transmission of COVID-19

SARS-COV-2 Infection

France
Karolinska University Hospital

Completed

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare

SARS-CoV 2

Sweden
Seqirus

Withdrawn

An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older

Influenza
AstraZeneca

Completed

Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069

Uncontrolled and Persistent Asthma

United Kingdom
Novavax

Completed

A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) (COVID-19)

SARS-CoV-2 Infection

South Africa
Assistance Publique - Hôpitaux de Paris

Unknown

Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV)

Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020

France
University of Campania "Luigi Vanvitelli"

Completed

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

Non-Alcoholic Fatty Liver Disease

Italy
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Respiratory Syncytial Virus Infections

United States, Australia, Germany, Czechia
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
Vinbiocare Biotechnology Joint Stock Company
Arcturus Therapeutics, Inc.

Completed

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) (ARCT-154-01)

COVID-19 Vaccines

Vietnam
Jiangsu Province Centers for Disease Control and...
Academy of Military Medical Sciences，Academy of Military Sciences，PLA; ZHONGYIANKE... and other collaborators

Recruiting

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

COVID-19

China
Direction Centrale du Service de Santé des Armées
University Hospital, Grenoble

Terminated

Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. (PLASCOSSA)

COVID-19

France
Novavax

Completed

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Covid19 | SARS-CoV Infection

Australia
GlaxoSmithKline

Completed

A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Respiratory Syncytial Virus Infections

Germany, Estonia, Belgium, France
GlaxoSmithKline

Completed

Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

Influenza

Spain
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Centre Hospitalier Universitaire de Nīmes

Active, not recruiting

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives. (VACTICOV2)

CORONAVIRUS INFECTIONS

France
Assistance Publique - Hôpitaux de Paris

Completed

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO (COVISEP)

COVID-19 | Multiple Sclerosis | NMO Spectrum Disorder

France
Kingman Regional Medical Center

Completed

Prevalence of COVID-19 Antibodies Kingman AZ

Covid19

United States
Kern Medical Center

Completed

Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic

COVID-19 | Social Determinants of Health | Penetrating Injury

United States
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Assistance Publique - Hôpitaux de Paris

Completed

Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns (COVIPREG)

Pregnancy

France
Grand Hôpital de Charleroi

Completed

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

Covid19

Belgium
Al-Azhar University
Ain Shams University; South Valley University; Helwan University; National Liver...

Completed

Non-invasive Predictors of ICU Admission and Mortality in Initially Asymptomatic COVID-19 Patients (COVID-HRCT)

COVID-19

Egypt
Assistance Publique - Hôpitaux de Paris
PRODISS; WEEZEVENT

Completed

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event (SPRING)

Covid19

France
University Hospital, Caen

Completed

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Vaccine Adverse Reaction

France
GlaxoSmithKline

Withdrawn

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Respiratory Syncytial Virus Infections

Finland, United States, Spain
University of Alabama at Birmingham
ViraCor Laboratories

Withdrawn

COVID Vaccine Immunity in Kidney Transplant Recipients

End Stage Renal Disease | Kidney Transplant; Complications
Zhongnan Hospital

Recruiting

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

SARS-CoV-2 | Safety | Immunotoxicity

China
Universidad de Antioquia
Laboratorio integrado de medicina especializada(LIME); Proyecto de regalias...

Recruiting

Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

COVID-19

Colombia
Jiangsu Province Centers for Disease Control and...
West China Hospital

Completed

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

COVID-19

China
University Hospital, Geneva

Completed

Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu)

Pneumonia | Covid19

Switzerland
Fundación Santa Fe de Bogota

Unknown

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

Covid-19 | Sars-CoV2

Colombia
University of Erlangen-Nürnberg Medical School

Recruiting

SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) (SARS-CoV2_KIDS)

SARS-Cov2

Germany
University of Florence
Azienda Ospedaliero-Universitaria Careggi

Completed

COVID-19 (SARS-CoV-2) in Urine and Semen

SARS-CoV 2 | Urine | Sexual Function and Fertility Disorders | Semen | Urinary Function Disorders

Italy
Hannover Medical School
Else Kröner Fresenius Foundation

Recruiting

Priming of the NEonatal Immune System by Transfer of Maternal Immunity (NEST)

COVID-19 | Respiratory Infections in Children | Maternal Vaccine Exposure

Germany
Dana-Farber Cancer Institute

Recruiting

Resilience and Equity in Aging, Cancer, and Health (REACH) (REACH)

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer

United States
Elizabeth Glaser Pediatric AIDS Foundation
UNITAID; Kenya Ministry of Health; Ministry of Public Health, Cameroon

Completed

Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya

COVID-19

Cameroon, Kenya
Hospital Italiano de Buenos Aires
Hospital de Niños R. Gutierrez de Buenos Aires; Salud Comunitaria Ministerio...

Completed

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina

SARS-CoV-2

Argentina
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland

Search clinical trials for: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations